Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This study (the SAVANNAH study) will investigate the efficacy of osimertinib in combination with savolitinib in patients with EGFRm+ and MET+, locally advanced or metastatic NSCLC who have progressed following treatment with osimertinib
Epistemonikos ID: bcb34fa36210b6970488affcee08dafb104254fd
First added on: May 21, 2024